DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 52 · February 2019 DOI: 10.1055/s-009-42493

Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Abstracts of the 1st Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Seminaris Campus Hotel Berlin, Germany, 06.–08.03.2019

Editors: Manfred Gerlach, Würzburg; Jürgen Deckert, Würzburg; Sabine Herpertz, Heidelberg; Jens Wiltfang, Göttingen

P2.2
Murck, H; Luerweg, B; Hahn, J; Braunisch, M; Jezova, D; Jansen, A; Kircher, T: Structural brain parameters and treatment outcome in major depression – neuroendocrine determinants
P2.4
Albantakis, L; Brandi, M; Henco, L; Lahnakoski, J; Dethloff, F; Brem, A; Gebert, D; Auer, M; Kopczak, A; Turck, C; Schilbach, L: The oxytocin study: A translational approach from molecular biology to behaviour analysis
P2.6
Moschny, N; Neyazi, A; Jahn, K; Maier, H; Bajbouj, M; Dorda, M; Davenport, C; Wiehlmann, L; Ballmaier, M; Bleich, S; Frieling, H: Electroconvulsive therapy response prediction: A new role for plasminogen activator inhibitor and tissue-type plasminogen activator?
P2.7
Mikoteit, T; De Witte, M; Holsboer-Trachsler, E; Hatzinger, M; Beck, J; Pawlowski, M: Sleep stage related heart rate variability distinguishes between insomnia and normal sleep
P2.8
Besse, M; Methfessel, I; Folsche, T; Vogelgsang, J; Wiltfang, J; Zilles, D: Neurofilament light chain as a marker of neuronal damage remains stable during a course of electroconvulsive therapy